Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank
Human Brain Mapping · 2024-02 · 45 (2)
DOI: 10.1002/hbm.26612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Brain Mapping, online erschienen am 02.02.2024. Verfasst von Ananthan Ambikairajah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Psychology, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swiss National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, University of Canberra.
Abstract (Originalsprache)
Global prevalence of Alzheimer's Disease has a strong sex bias, with women representing approximately two‐thirds of the patients. Yet, the role of sex‐specific risk factors during midlife, including hormone replacement therapy (HRT) and their interaction with other major risk factors for Alzheimer's Disease, such as apolipoprotein E (APOE)‐e4 genotype and age, on brain health remains unclear. We investigated the relationship between HRT (i.e., use, age of initiation and duration of use) and brain health (i.e., cognition and regional brain volumes). We then consider the multiplicative effects of HRT and APOE status (i.e., e2/e2, e2/e3, e3/e3, e3/e4 and e4/e4) via a two‐way interaction and subsequently age of participants via a three‐way interaction. Women from the UK Biobank with no self‐reported neurological conditions were included ( N = 207,595 women, mean age = 56.25 years, standard deviation = 8.01 years). Generalised linear regression models were computed to quantify the cross‐sectional association between HRT and brain health, while controlling for APOE status, age, time since attending centre for completing brain health measure, surgical menopause status, smoking history, body mass index, education, physical activity, alcohol use, ethnicity, socioeconomic status, vascular/heart problems and diabetes diagnosed by doctor. Analyses of structural brain regions further controlled for scanner site. All brain volumes were normalised for head size. Two‐way interactions between HRT and APOE status were modelled, in addition to three‐way interactions including age. Results showed that women with the e4/e4 genotype who have used HRT had 1.82% lower hippocampal, 2.4% lower parahippocampal and 1.24% lower thalamus volumes than those with the e3/e3 genotype who had never used HRT. However, this interaction was not detected for measures of cognition. No clinically meaningful three‐way interaction between APOE, HRT and age was detected when interpreted relative to the scales of the cognitive measures used and normative models of ageing for brain volumes in this sample. Differences in hippocampal volume between women with the e4/e4 genotype who have used HRT and those with the e3/e3 genotype who had never used HRT are equivalent to approximately 1–2 years of hippocampal atrophy observed in typical health ageing trajectories in midlife (i.e., 0.98%–1.41% per year). Effect sizes were consistent within APOE e4/e4 group post hoc sensitivity analyses, suggesting observed effects were not solely driven by APOE status and may, in part, be attributed to HRT use. Although, the design of this study means we cannot exclude the possibility that women who have used HRT may have a predisposition for poorer brain health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Psychology, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia.
- Centre for Ageing Research and Translation, Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia.
- National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.
- Norwich Medical School, University of East Anglia, Norwich, UK.
- Norfolk and Norwich NHS Trust, Norwich, UK.
- Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
ORCID-Profile: Ananthan Ambikairajah, Mizanur Khondoker, Ann-Marie G de Lange, Rasha N M Saleh, Anne Marie Minihane, Michael Hornberger
Förderung
- Swiss National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- University of Canberra
Zitieren
APA
Ambikairajah, A., Khondoker, M., Morris, E., de Lange, A. G., Saleh, R. N. M., Minihane, A. M., & Hornberger, M. (2024). Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank. Human Brain Mapping, 45(2). https://doi.org/10.1002/hbm.26612
Vancouver
Ambikairajah A, Khondoker M, Morris E, de Lange AG, Saleh RNM, Minihane AM, et al. Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank. Human Brain Mapping. 2024;45(2). doi:10.1002/hbm.26612
BibTeX
@article{Ambikairajah2024,
author = {Ambikairajah, Ananthan and Khondoker, Mizanur and Morris, Edward and de Lange, Ann-Marie G and Saleh, Rasha N M and Minihane, Anne Marie and Hornberger, Michael},
title = {Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank},
journal = {Human Brain Mapping},
year = {2024},
volume = {45},
number = {2},
doi = {10.1002/hbm.26612}
}
EUVIMED